NovoCure Ltd

NASDAQ:NVCR

12.09

+0.04 (+0.33%)

6:47:23 PM EDT: $12.19 +0.10 (+0.83%)

Market Cap (Intraday)	1.29B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$131.76 Million
Adjusted EPS	-$0.42

See more estimates

10-Day MA	$12.95
50-Day MA	$14.74
200-Day MA	$18.39

See more pivots

NovoCure Ltd Stock, NASDAQ:NVCR

No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF

Jersey

Phone: +44.15.3475.6700

Number of Employees: 1453

http://www.novocure.com

Description

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.